Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application

Front Oncol. 2022 Jun 30:12:902820. doi: 10.3389/fonc.2022.902820. eCollection 2022.

Abstract

Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further consideration on humans. Therefore, appropriate models for the study of the pathogenesis of the disease and related treatment methods are necessary. For tumor research, mouse models are the most commonly used and effective in vivo model, which is closer to the real-life environment, and the repeated experiments performed on it are closer to the real situation. Several mouse models of HCC have been developed with different mouse strains, cell lines, tumor sites, and tumor formation methods. In this review, we mainly introduce some mouse HCC models, including induced model, gene-edited model, HCC transplantation model, and other mouse HCC models, and discuss how to choose the appropriate model according to the purpose of the experiments.

Keywords: gene-edited mice; hepatocellular carcinoma; metastasis; mouse model; transplantation model.

Publication types

  • Review